
About Waft Pharma Private Limited
Data last updated:
Waft Pharma Private Limited is a private limited company based in Rajamahendravaram, Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U33100AP2017PTC106922. Its GSTIN is 37AACCW0957B1ZH (Andhra Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Venkata Subbarao Gidugu and Venkata Ramaiah Tumati.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Rajamahendravaram, Andhra Pradesh.
As per the financials filed for FY 2022, the company reported a revenue of ₹30.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.19 Lakh (net margin -10.5%) and EBITDA of -₹3.11 Lakh (EBITDA margin -10.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
The company is associated with 1 brand: WAFT Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website waftpharma.com.
Company details
Contact details
Waft Pharma Private Limited's registered office is in Rajamahendravaram, Andhra Pradesh. Its website is waftpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address74 – 2 – 5/1 1st Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Waft Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Waft Pharma operates one associated brand: WAFT Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures a range of pharmaceutical products, including tablets, capsules, syrups, liquids, ointments, and injections. | waftpharma.com |
Business activity
The main business activity of Waft Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Waft Pharma Private Limited, buy the company report.
Financials of Waft Pharma Private Limited
FY 2022 filings availableWaft Pharma Private Limited reported revenue of ₹30.37 Lakh (up 4519% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over three years. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10.2% | ||||
| Net Profit Margin | -10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Waft Pharma Private Limited, buy the company report.
Board of directors of Waft Pharma Private Limited
Waft Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkata Subbarao Gidugu | Director | 21 Oct 2020 | 6 Years 0 Months | Current |
| Venkata Ramaiah Tumati | Director | 31 Mar 2018 | 8 Years 7 Months | Current |
| Surya Chandra Sekhara Rao Samsani | Director | 26 Oct 2017 | 9 Years 0 Months | Current |
| Sai Dileep Viswanadha Also directs: Neura Cube LLP, Doctoevo Healthcare Private Limited | Director | 26 Oct 2017 | 9 Years 0 Months | Current |
| Santhi Sree Tumati | Director | 26 Oct 2017 | 9 Years 0 Months | Current |
Shareholding
The shareholding of Waft Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Waft Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Waft Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Waft Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Waft Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AACCW0957B1ZH | Andhra Pradesh | Active | 07 Dec 2017 |
To see the full GST registrations and return filing status of Waft Pharma Private Limited, buy the company report.
Recent activity
Waft Pharma Private Limited has 7 board changes on record since 2017: 5 appointments and 2 cessations. The latest: Venkata Subbarao Gidugu was appointed as Director on 21 Oct 2020.
Frequently asked questions
Waft Pharma is an active private limited company based in Rajamahendravaram, Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2017 (9+ years old) and is registered under CIN U33100AP2017PTC106922.
Waft Pharma has 5 current directors:
- Venkata Subbarao Gidugu - Director
- Venkata Ramaiah Tumati - Director
- Surya Chandra Sekhara Rao Samsani - Director
- Sai Dileep Viswanadha - Director
- Santhi Sree Tumati - Director
The latest financial statements of Waft Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Waft Pharma is 37AACCW0957B1ZH, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Waft Pharma is U33100AP2017PTC106922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Waft Pharma was incorporated on 26 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Vijayawada.
Venkata Subbarao Gidugu was appointed as Director on 21 Oct 2020. Bala Sadasivuni ceased to be Director on 31 Mar 2018. Sudhakar Seetamraju ceased to be Director on 31 Mar 2018. Waft Pharma has 7 board changes on record in total.
Waft Pharma can be reached through the website waftpharma.com. Its registered office is in Rajamahendravaram, Andhra Pradesh, India.
The registered office of Waft Pharma is at 74 – 2 – 51 1st Floor Opposite Niveditha Kishore Public School Addepalli Colony Ava Roa, D, Rajamahendravaram, Andhra Pradesh, India – 533103.
Waft Pharma operates in the pharma industry, in the drug formulation and development segment.

